Moderators: Elvis, DrVolin, Jeff
Rimonabant (also known as SR141716, Acomplia, Bethin, Monaslim, Remonabent, Riobant, Slimona, Rimoslim, and Zimulti[1], Riomont) is an anorectic anti-obesity drug. It is an inverse agonist for the cannabinoid receptor CB1. Its main avenue of effect is reduction in appetite.
In October, 2008, the European Medicines Agency recommended that doctors not prescribe the drug due to the risk of serious psychiatric problems and even suicide. The drug was subsequently suspended.
Penguin wrote:Still not smoking
How are you others hangin?
Sweejak wrote:Penguin wrote:Still not smoking
How are you others hangin?
Still plodding along, I'm up to 5 pm.
Return to The Lounge & Member News
Users browsing this forum: No registered users and 2 guests